1. This minimally invasive test could change gastroesophageal reflux disease screening
Click here
2. 4 Baylor physicians meet with Rep. Gene Green
Click here
3. Florida jury finds gastroenterologist not liable in alleged ‘slapdash colonoscopy’ trial — 6 insights
Click here
4. Boston Scientific continues to pour money into endoscopy — Why?
Click here
5. Amid struggling sales, Takeda’s CEO goes all in on globalization
Click here
More articles on gastroenterology:
This minimally invasive test could change gastroesophageal reflux disease screening
4 Baylor physicians meet with Rep. Gene Green
Florida jury finds gastroenterologist not liable in alleged ‘slapdash colonoscopy’ trial — 6 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.